After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and Biogen
Published
Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies. It's the first drug for treatment of the disease in a country with a rapidly aging population. Developed by Japanese drugmaker Eisai Co. and U.S.…
#leqembi #eisaico #biogeninc #fumiokishida #healthministry #eisai #kyodonews #haruonaito